6533b822fe1ef96bd127cb3b
RESEARCH PRODUCT
Upregulated Mirna 21 in Kras Mutated Patients is Related to Prognosis in Resectable Non-Small Cell Lung Cancer
Carlos CampsS. GallachEloisa Jantus-lewintreRicardo GuijarroSilvia Calabuig-fariñasAna BlascoE. EscorihuelaD. Montanersubject
Oncologymedicine.medical_specialtybusiness.industryHematologymedicine.diseasemedicine.disease_causeOncologyInternal medicineMutation (genetic algorithm)microRNAmedicineNon small cellKRASbusinessLung canceryear | journal | country | edition | language |
---|---|---|---|---|
2015-04-01 | Annals of Oncology |